Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Alumni
  • Login
  • Volunteer
  • Clubs
  • Reunions
  • Magazine
  • Class Notes
  • Help
  • Give Now
  • Stories
  • Alumni Directory
  • Lifelong Learning
  • Careers
  • Programs & Events
  • Giving
  • …→
  • Harvard Business School→
  • Alumni→
  • Stories→

Stories

Stories

01 Dec 2020

Digital Health Care: Empowering Consumers

Q&A with Professor Regina Herzlinger
Re: Regina E. Herzlinger (Nancy R. McPherson Professor of Business Administration); By: April White
Topics: Health-Health Care and TreatmentInnovation-Technological InnovationMarkets-Demand and Consumers
ShareBar

Regina Herzlinger, the Nancy R. McPherson Professor of Business Administration, has been studying the health care sector for nearly half a century. In that time, she has seen significant innovation in the field—and she has also seen the powerful sway of the status quo, which has led to the slow adoption of some cost-reducing, consumer-facing, and life-saving technology innovations. Herzlinger—dubbed the “godmother of consumer-driven health care”—has helped to shepherd countless new health care products to market. But she’s never seen the health care landscape change at the pace that has occurred in 2020. “COVID-19 is a dreadful pandemic,” she says in the following discussion, “but it has turned everything upside down in the health care sector in some good ways.”

What are the most interesting digital health care innovations to emerge in recent years?

I have been watching wearable sensors, like smart watches, and telemedicine, which is a companion to these sensors. Both have become more powerful and more acceptable to consumers and to the health care industry, which has resisted these innovations for a long time. I am also sanguine about implantable sensors, which can monitor symptoms of diseases like diabetes or congestive heart failure. Before the implantable congestive heart failure monitor, for example, we had very poor diagnostic tools to alert the need for ASAP therapy, but these sensors can now alert providers when therapeutic treatments are needed.

What has driven these trends?

Professor Regina Herzlinger on creating breakthrough services, products, and business models in health care

Consumers are busy. It used to be that we called health care consumers “patients,” as in “wait and be patient.” But hard-working consumers are demanding convenience. We’ve seen that in the growth of retail medical centers, too. If they are conveniently located, people will take care of minor medical issues, such as an ache, or a mole that might be cancerous. Most people also prefer them to hospitals overwhelmed with COVID-19 patients. With more two-career families and single head-of-household families, with more people who are taking care of both their children and their elderly loved ones, it is clear that retail medical health care innovation is going to become a very powerful movement. It will be especially useful for coordinating monitoring and some therapy for people with chronic diseases or disabilities who are frequently lost among the cracks of our present fragmented system.

How has the pandemic changed the health care sector?

We have seen a much broader acceptance of telemedicine and changes in who can deliver telemedicine, where it can be used, and, most importantly, equality of pay between in-office visits and telemedicine visits. In the past, providers were paid at much lower rates for telemedicine visits. That sounds fair, but telemedicine is actually expensive. It can cost tens of thousands of dollars a year for the necessary equipment. With COVID-19, there has been such a need—who wants to go to the hospital for a sore throat in a pandemic? In addition, what hospital wants to see them?

The acceptance of telemedicine has also led to a boom in wearable sensors. Apple came out with an app that measures how oxygenated your blood is. That’s a very important marker for COVID-19. When they debuted, smart watches seemed like sort of silly pieces of technology people used to count 10,000 steps, but they are becoming very important in giving early warning signs about dangerous problems with our bodies.

Do you expect these changes will persist?

See more from the online-only December Alumni Bulletin Impact section’s exploration of how the digital revolution has improved health care delivery and discovery.

Digital Transformation of Health Care

See more from the online-only December Alumni Bulletin Impact section’s exploration of how the digital revolution has improved health care delivery and discovery.

Digital Transformation of Health Care

I think there will be enormous consumer backlash if we limp back to the old days when you could only get access to telemedicine if you were in a prison or in a rural area, and only doctors who worked in your state could provide it and they would be paid $3.50 (I am kidding!) for the telemedicine visit. The politicians, doctors, and hospitals who once pulled the power of the status quo to suppress telemedicine are all going to face a new force, which is consumers saying, “This makes my complicated life so much better.”

Will the health care sector embrace artificial intelligence?

I think it could be a powerful tool for routinizing the practice of medicine. Artificial intelligence digs through mounds and mounds of data and finds where medical practice is great and where it’s not so great. However, I am dubious about its quick acceptance by the medical profession. If I’m a doctor who is world renowned for how I operate on a shoulder, and AI tells me that what I’m doing is not best in class, am I going to change? I don’t think so. It’ll be a tough battle.

What is the most important lesson for aspiring health care entrepreneurs?

Professor Regina Herzlinger
Offers a
preview of her upcoming book

Professor Regina Herzlinger
Offers a
preview of her upcoming book

Frequently, innovators are so in love with their innovation that they believe if they build it, the health care sector will come. But this is a highly regulated, technology-intensive industry with third-party payers, not a retail industry. It’s a very unusual sector and you need to know a lot about how it works. How do you align your innovation with that environment? Can you provide enough data so that payers and providers feel comfortable about adopting your innovation? Can you make it the standard of care, meaning it is something doctors have to do? Can you get Medicare to pay for it?

The MBA elective course I teach, Innovating in Health Care, supports and enables innovators. It helps students—not just MBA students, but also those from Harvard’s medical school, engineering school, and public policy and health school—understand how to disseminate their health care innovation ideas. If they are very serious about it, the second course, a field-study course, enables them to spend the entire term working on that idea with help from successful entrepreneurs in a variety of fields.

What do you see for the future of the health care sector?

Lately, I’ve become optimistic. It’s a big struggle to turn from an industry in which the suppliers are dominant and dictate what happens to an industry where the consumers have a voice. These new technologies have empowered consumers to monitor and manage their own diseases.

MORE STORIES ABOUT IMPACT:


The Digital
Transformation
of Health Care


A New Approach to Contact Tracing


Finding the Right Patient-Provider Match


AI Enhances Diagnostic Care

ShareBar

Post a Comment

Featured Faculty

Regina E. Herzlinger
Nancy R. McPherson Professor of Business Administration

Related Stories

    • 01 Mar 2025
    • HBS Magazine

    Venture: Time Heals All

    Re: Ilana Springer (MBA 2022); Eric Gruskin (MBA 2022); By: Amy Crawford; Illustration by Klaus Kremmerz
    • 15 Dec 2024
    • HBS Magazine

    Agenda: Amanda E/J Morrison (MBA 2014)

    Re: Amanda Johnson (MBA 2014); By: Janelle Nanos
    • 15 Dec 2024
    • HBS Magazine

    On The Case

    Re: Tomislav Mihaljevic (GMP 15); Linda A. Hill (Wallace Brett Donham Professor of Business Administration); By: Jen McFarland Flint
    • 15 Dec 2024
    • HBS Magazine

    After Ozempic

    Re: Kate Mulroney (MBA 1984); Joseph L. Badaracco (John Shad Professor of Business Ethics); By: Jen McFarland Flint; Illustrations by Pete Ryan

More Related Stories

 
 
 
ǁ
Campus Map
External Relations
Harvard Business School
Teele Hall
Soldiers Field
Boston, MA 02163
Phone: 1.617.495.6890
Email: alumni+hbs.edu
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
  • Terms of Use
Copyright © President & Fellows of Harvard College.